Doug Jermasek

Senior Vice President, North America & Global Marketing
Intercept Pharmaceuticals, Inc.

Doug Jermasek is Senior Vice President, North America & Global Marketing at Intercept Pharmaceuticals, Inc. He is a commercial biopharma leader with previous senior roles at Genzyme/Sanofi, SVP & GM Global Renal Division; Prometheus, VP, Marketing; Agouron/Pfizer, Senior Director, Marketing; Abbott Labs, Marketing & Sales management.

Check out the incredible speaker line-up to see who will be joining Doug.

Download The Latest Agenda

Day 2

Sunday, April 10th, 2016

11:25 PANEL: Determining How Health Economics And Pricing Reimbursement Are Impacting Research Outcomes And Partnering Strategy

• Examining the current state of pricing reimbursement globally; what are the differences among Europe, the US, and other areas you work in?

• Explaining why health outcomes research so important to your potential partners; Will it continue to be a major driver?

• Debating whether health economics and research outcomes need to be incorporated into clinical trials no later than phase 2, and perhaps even in phase 1

• Establishing how health economic and research outcome data either drive value or cripple your opportunity for partnering